Contract HHSO100201700007C
Emergent Biodefense Operations Lansing Llc · Department Of Health And Human Services · March 16, 2017
Emergent Biodefense Operations Lansing Llc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on March 16, 2017 for $99.94 million of work in research and development in biotechnology. Performance is in Lansing, MI. It was awarded under full and open competition. It uses firm fixed-price contract pricing.
Contract details
- PIID
- HHSO100201700007C
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 541711 · Research And Development In Biotechnology
- Product / service
- R&D- Medical: Biomedical (Advanced Development)
- Place of performance
- Lansing, MI
- First action
- March 16, 2017
Description
IGF::OT::IGF
Modification timeline
-
March 16, 2017Base award$99.94M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| University Of Illinois | Department Of Health And Human Services | March 26, 2026 | $2.27M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 25, 2026 | $9.65M |
| University Of Texas Medical Branch At Galveston | Department Of Health And Human Services | March 23, 2026 | $1.61M |
| Regeneron Pharmaceuticals Inc | Department Of Health And Human Services | March 19, 2026 | $8.60M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.23M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.22M |
Top contractors in NAICS 541711
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Alliance For Energy Innovation, Llc | 2 | $10.68B |
| 2 | Emergent Product Development Gaithersburg Inc. | 7 | $1.63B |
| 3 | Janssen Pharmaceuticals, Inc. | 2 | $1.05B |
| 4 | Regeneron Pharmaceuticals Inc | 4 | $1.01B |
| 5 | Siga Technologies, Inc. | 3 | $560.59M |
| 6 | Battelle National Biodefense Institute, Llc | 106 | $469.31M |
| 7 | Glaxosmithkline, Llc | 6 | $321.65M |
| 8 | Merck Sharp & Dohme Llc | 3 | $309.72M |
| 9 | Sri International | 130 | $258.61M |
| 10 | American Type Culture Collection | 7 | $243.18M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSO100201700007C?
Contract HHSO100201700007C is a federal contract awarded to Emergent Biodefense Operations Lansing Llc by Department Of Health And Human Services on March 16, 2017 for $99.94 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 0 times since the base award.
Who won contract HHSO100201700007C?
Emergent Biodefense Operations Lansing Llc won contract HHSO100201700007C from Department Of Health And Human Services.
How much is contract HHSO100201700007C worth?
Contract HHSO100201700007C has obligated $99.94 million to date.